Journal profile · MEDICINE, GENERAL & INTERNAL-PHARMACOLOGY & PHARMACY
Australian Prescriber
ISSN 0312-8008 · eISSN 1839-3942 · National Prescribing Service · AUSTRALIA · Bimonthly · Founded 1975
Australian Prescriber: CAS Zone 2 · Medicine (2025 upgraded edition); diamond open access (no APC); no APC; review over 12 weeks (community reports); community-reported acceptance: easy; 57 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Australian Prescriber is published by National Prescribing Service and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical Economics and Policy, Pharmaceutical studies and practices and Cancer Treatment and Pharmacology, together about 26.6% of its articles. Its main subfields are Pharmacology. (generated from OpenAlex topic counts and CAS ranking data)
As an independent review of therapeutics, Australian Prescriber aims to provide expert, balanced, impartial, reliable and up-to-date information for its readers by reviewing recent evidence where therapy is evolving and updating readers on therapeutics in their own and other fields. Australian Prescriber is a review journal and does not publish original research or original clinical trial data. In addition to editorials and articles, Australian Prescriber includes regular features such as medication mishaps, and articles on the appropriate use of diagnostic tests and the interpretation of abnormal laboratory results. Each issue includes brief comments on drugs that have recently been marketed in Australia.
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, GENERAL & INTERNAL-PHARMACOLOGY & PHARMACY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance9.2%
- Pharmaceutical studies and practicesMedicine8.9%
- Cancer Treatment and PharmacologyMedicine8.5%
- Pharmaceutical Practices and Patient OutcomesMedicine6.7%
- Pharmaceutical industry and healthcarePharmacology, Toxicology and Pharmaceutics6.3%
- Pharmacological Effects and Toxicity StudiesMedicine5.7%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance5.3%
- Antibiotics Pharmacokinetics and EfficacyMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedEmbasePublisher website
Other: Academic Search Complete, Academic Search Ultimate, Biomedical Reference Collection: Corporate, Publicly Available Content Database
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 4.3LetPub ·
- SJR 2026-06
- 0.69LetPub ·
- SNIP 2026-06
- 1.03LetPub ·
- h-index
- 21LetPub ·
- h-index
- 62OpenAlex ·
- i10-index
- 455OpenAlex ·
- 2-year mean citedness
- 2.92OpenAlex ·
- Self-citation rate
- 2.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 23LetPub ·
Articles by year OpenAlex count · 3,216 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 35 | 35 | 8 |
| 2025 | 57 | 57 | 173 |
| 2024 | 56 | 56 | 251 |
| 2023 | 32 | 32 | 237 |
| 2022 | 78 | 78 | 508 |
| 2021 | 75 | 75 | 668 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to publication (journal-reported)
- about 36 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-ND | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, License & copyright, Open access, Peer review
- Authorship Authorship
All authors listed on an article must have contributed in a meaningful way and be accountable for any questions regarding its accuracy and integrity. Authors will be asked to nominate a corresponding author who will take responsibility for communicating with the journal during the publication process. Before publication, authors must declare that the paper is their own work, it has not been previo…
Source ↗Publisher website ·- Conflicts of interest Conflicts of interest
Conflict of interest policy Model summary
Authors of articles for Australian Prescriber are asked to provide a written interest statement related to the article at the time of commissioning. Interests may be academic, professional, commercial or personal, and may be financial or non-financial. The Editorial Advisory Committee will decide if any declared interests of authors should be published based on a consideration of whether they are …
Source ↗Publisher website ·- License & copyright Copyright
Copyright belongs to Therapeutic Guidelines Ltd. Australian Prescriber is an Open Access journal which means that all content is freely available. Individuals are allowed to read, download, print, search or link to the full text of the articles, or use them for any other lawful purpose without asking prior permission from the publisher or the author, provided that the source of the material is ack…
Source ↗Publisher website ·- Open access
Copyright and open access policy Model summary
Except where otherwise noted, all articles published in Australian Prescriber can be used under the CC BY-NC-ND licence.
Source ↗Publisher website ·- Peer review
Peer review policy Model summary
All commissioned articles undergo a rigorous editorial process, including external peer review, before being accepted for publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- National Prescribing Service
- Country or region
- AUSTRALIA
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1975
- ISSN
- 0312-8008
- Electronic ISSN
- 1839-3942
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Australian Prescriber
What CAS zone is Australian Prescriber in?
In the 2025 upgraded edition of the CAS Journal Ranking, Australian Prescriber is in Zone 2 of Medicine, and in Zone 2 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Australian Prescriber?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Australian Prescriber?
According to LetPub and DOAJ records, Australian Prescriber is indexed in ESCI, Scopus and DOAJ. The journal's website also lists PubMed and Embase; that list has not been checked against each database.
Is Australian Prescriber open access, and what is the APC?
Australian Prescriber is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .